The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Open accessAbstract
Psoriasis is a frequent chronic inflammatory skin disease, nowadays considered a major global health problem. Several new drugs, targeting the IL-23/IL-17A pathway, have been recently licensed or are in clinical development. These therapies represent a major improvement of the way in which psoriasis is managed, since they show an unprecedented efficacy on skin symptoms of psoriasis. This has been made possible, thanks to an increasingly more accurate pathogenic view of psoriasis. Today, the belief that Th17 cells mediate psoriasis is moving to the concept of psoriasis as an IL-17A-driven disease. New questions arise at the horizon, given that IL-17A is part of a newly described family of cytokines, which has five distinct homologous: IL-17B, IL-17C, IL-17D, IL-17E, also known as IL-25 and IL-17F. IL-17 family cytokines elicit similar effects in target cells, but simultaneously trigger different and sometimes opposite functions in a tissue-specific manner. This is complicated by the fact that IL-17 cytokines show a high capacity of synergisms with other inflammatory stimuli. In this review, we will summarize the current knowledge around the cytokines belonging to the IL-17 family in relation to skin inflammation in general and psoriasis in particular, and discuss possible clinical implications. A comprehensive understanding of the different roles played by the IL-17 cytokines is crucial to appreciate current and developing therapies and to allow an effective pathogenesis- and mechanisms-driven drug design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 5×
“J Eur Acad Dermatol Venereol (2013) 27(11): 1387–404.”
BackgroundInfluentialOppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Self-citationLiang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187
Ishigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, N., Tanahashi, Y., Akitsu, A., Kotaki, H., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.009 · Cited by 1,004 · cited 3×
“roles on CIA and arthritis in Il1rn−/− mice (72, 74).”
BackgroundHerpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
Salimi, M., Barlow, J. L., Saunders, S. P., Xue, L., Gutowska-Owsiak, D., Wang, X., Huang, L.-C., Johnson, D., Scanlon, S. T., McKenzie, A. N. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130351 · Cited by 979
Psoriasis pathogenesis and the development of novel targeted immune therapies
Hawkes, J. E., Chan, T. C., & Krueger, J. G. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.004 · Cited by 972
Schön, M. P., & Boehncke, W.-H. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041320 · Cited by 955
Self-citationMast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
Lin, A. M., Rubin, C. J., Khandpur, R., Wang, J. Y., Riblett, M., Yalavarthi, S., Villanueva, E. C., Shah, P., Kaplan, M. J., & Bruce, A. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100123 · Cited by 906
Griffiths, C. E. M., Reich, K., Lebwohl, M., van de Kerkhof, P., Paul, C., Menter, A., Cameron, G. S., Erickson, J., Zhang, L., Secrest, R. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60125-8 · Cited by 834
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Lebwohl, M., Strober, B., Menter, A., Gordon, K., Weglowska, J., Puig, L., Papp, K., Spelman, L., Toth, D., Kerdel, F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503824 · Cited by 828
Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 804
IL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
Rouvier, E., Luciani, M. F., Mattéi, M. G., Denizot, F., & Golstein, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5445 · Cited by 775
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
Lee, J. S., Tato, C. M., Joyce-Shaikh, B., Gulen, M. F., Cayatte, C., Chen, Y., Blumenschein, W. M., Judo, M., Ayanoglu, G., McClanahan, T. K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.003 · Cited by 760
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B., Barrat, F. J., Zal, T., & Gilliet, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090480 · Cited by 740
Regulation of inflammatory responses by IL-17F
Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.-H., Schluns, K. S., Broaddus, R. R., Zhu, Z., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071978 · Cited by 739 · cited 2×
“– Animal models: IL-17F contributes to experimental induced colitis (76, 82)”
BackgroundFallon, P. G., Ballantyne, S. J., Mangan, N. E., Barlow, J. L., Dasvarma, A., Hewett, D. R., McIlgorm, A., Jolin, H. E., & McKenzie, A. N. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051615 · Cited by 738
Chiricozzi, A., Guttman-Yassky, E., Suárez-Fariñas, M., Nograles, K. E., Tian, S., Cardinale, I., Chimenti, S., & Krueger, J. G. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.340 · Cited by 686
Chan, J. R., Blumenschein, W., Murphy, E., Diveu, C., Wiekowski, M., Abbondanzo, S., Lucian, L., Geissler, R., Brodie, S., Kimball, A. B., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060244 · Cited by 680
Gottlieb, S. L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T. G., Gottlieb, A. B., & Krueger, J. G. (1995) · Nature Medicine · doi:10.1038/nm0595-442 · Cited by 606
Cyclosporine Improves Psoriasis in a Double-blind Study
Ellis, C. N. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380220076026 · Cited by 558
Interleukin 25 promotes the initiation of proallergic type 2 responses
Angkasekwinai, P., Park, H., Wang, Y.-H., Wang, Y.-H., Chang, S. H., Corry, D. B., Liu, Y.-J., Zhu, Z., & Dong, C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061675 · Cited by 554
Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice
Pantelyushin, S., Haak, S., Ingold, B., Kulig, P., Heppner, F. L., Navarini, A. A., & Becher, B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61862 · Cited by 512
The Th17/Treg imbalance in patients with acute coronary syndrome
Cheng, X., Yu, X., Ding, Y.-J., Fu, Q.-Q., Xie, J.-J., Tang, T.-T., Yao, R., Chen, Y., & Liao, Y.-H. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.009 · Cited by 489
IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
Ramirez-Carrozzi, V., Sambandam, A., Luis, E., Lin, Z., Jeet, S., Lesch, J., Hackney, J., Kim, J., Zhou, M., Lai, J., et al. (2011) · Nature Immunology · doi:10.1038/ni.2156 · Cited by 477 · cited 6×
“Outside the skin, IL-17C promotes protective antimicrobial responses in the gut (96, 97, 101) and participates in mucosal responses to Citrobacter rodentium (97).”
BackgroundInfluentialThe Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
Martin, D. A., Towne, J. E., Kricorian, G., Klekotka, P., Gudjonsson, J. E., Krueger, J. G., & Russell, C. B. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.194 · Cited by 466
Carrier, Y., Ma, H.-L., Ramon, H. E., Napierata, L., Small, C., O'Toole, M., Young, D. A., Fouser, L. A., Nickerson-Nutter, C., Collins, M., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.234 · Cited by 425
IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1
Lee, J., Ho, W.-H., Maruoka, M., Corpuz, R. T., Baldwin, D. T., Foster, J. S., Goddard, A. D., Yansura, D. G., Vandlen, R. L., Wood, W. I., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008289200 · Cited by 405
IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B., & Waisman, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35997 · Cited by 399
IL-25 regulates Th17 function in autoimmune inflammation
Kleinschek, M. A., Owyang, A. M., Joyce-Shaikh, B., Langrish, C. L., Chen, Y., Gorman, D. M., Blumenschein, W. M., McClanahan, T., Brombacher, F., Hurst, S. D., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061738 · Cited by 396
Owyang, A. M., Zaph, C., Wilson, E. H., Guild, K. J., McClanahan, T., Miller, H. R. P., Cua, D. J., Goldschmidt, M., Hunter, C. A., Kastelein, R. A., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051496 · Cited by 379
Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma
Ballantyne, S. J., Barlow, J. L., Jolin, H. E., Nath, P., Williams, A. S., Chung, K. F., Sturton, G., Wong, S. H., & McKenzie, A. N. J. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.051 · Cited by 368
Papp, K. A., Langley, R. G., Sigurgeirsson, B., Abe, M., Baker, D. R., Konno, P., Haemmerle, S., Thurston, H. J., Papavassilis, C., & Richards, H. B. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12110 · Cited by 360
Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
Erbel, C., Chen, L., Bea, F., Wangler, S., Celik, S., Lasitschka, F., Wang, Y., Böckler, D., Katus, H. A., & Dengler, T. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901126 · Cited by 358
Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor
Chang, S. H., Park, H., & Dong, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600256200 · Cited by 356
Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family
Li, H., Chen, J., Huang, A., Stinson, J., Heldens, S., Foster, J., Dowd, P., Gurney, A. L., & Wood, W. I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.773 · Cited by 354
Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
Johansen, C., Usher, P. A., Kjellerup, R. B., Lundsgaard, D., Iversen, L., & Kragballe, K. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08902.x · Cited by 352
Schwandner, R., Yamaguchi, K., & Cao, Z. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1233 · Cited by 349
Interleukin 17A: Toward a new understanding of psoriasis pathogenesis
Lynde, C. W., Poulin, Y., Vender, R., Bourcier, M., & Khalil, S. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.12.036 · Cited by 335
Starnes, T., Broxmeyer, H. E., Robertson, M. J., & Hromas, R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.642 · Cited by 331
Seiderer, J., Elben, I., Diegelmann, J., Glas, J., Stallhofer, J., Tillack, C., Pfennig, S., Jürgens, M., Schmechel, S., Konrad, A., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20339 · Cited by 329
IL‐17 and IL‐22 in immunity: Driving protection and pathology
Eyerich, K., Dimartino, V., & Cavani, A. (2017) · European Journal of Immunology · doi:10.1002/eji.201646723 · Cited by 326
Song, X., Zhu, S., Shi, P., Liu, Y., Shi, Y., Levin, S. D., & Qian, Y. (2011) · Nature Immunology · doi:10.1038/ni.2155 · Cited by 312
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation
Johnston, A., Fritz, Y., Dawes, S. M., Diaconu, D., Al-Attar, P. M., Guzman, A. M., Chen, C. S., Fu, W., Gudjonsson, J. E., McCormick, T. S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201505 · Cited by 308
Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00579 · Cited by 307
Self-citationAkimzhanov, A. M., Yang, X. O., & Dong, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c600322200 · Cited by 302
Boisson, B., Wang, C., Pedergnana, V., Wu, L., Cypowyj, S., Rybojad, M., Belkadi, A., Picard, C., Abel, L., Fieschi, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.002 · Cited by 293 · cited 2×
“roles on CIA and arthritis in Il1rn−/− mice (72, 74).”
BackgroundRecent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283
IL-17 Enhances Chemokine Gene Expression through mRNA Stabilization
Hartupee, J., Liu, C., Novotny, M., Li, X., & Hamilton, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4135 · Cited by 282
Interleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E
Chang, S. H., Reynolds, J. M., Pappu, B. P., Chen, G., Martinez, G. J., & Dong, C. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.010 · Cited by 271
Glatt, S., Baeten, D., Baker, T., Griffiths, M., Ionescu, L., Lawson, A. D. G., Maroof, A., Oliver, R., Popa, S., Strimenopoulou, F., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212127 · Cited by 270
Lai, Y., Li, D., Li, C., Muehleisen, B., Radek, K. A., Park, H. J., Jiang, Z., Li, Z., Lei, H., Quan, Y., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.010 · Cited by 261
Kirkham, B. W., Kavanaugh, A., & Reich, K. (2014) · Immunology · doi:10.1111/imm.12142 · Cited by 243
Gutowska‐Owsiak, D., Schaupp, A. L., Salimi, M., Selvakumar, T. A., McPherson, T., Taylor, S., & Ogg, G. S. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01412.x · Cited by 238
CCR6 is required for IL-23–induced psoriasis-like inflammation in mice
Hedrick, M. N., Lonsdorf, A. S., Shirakawa, A.-K., Lee, C.-C. R., Liao, F., Singh, S. P., Zhang, H. H., Grinberg, A., Love, P. E., Hwang, S. T., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37378 · Cited by 238
Psoriasis: from Pathogenesis to Targeted Therapies
Conrad, C., & Gilliet, M. (2018) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8668-1 · Cited by 234
Sun, D., Novotny, M., Bulek, K., Liu, C., Li, X., & Hamilton, T. (2011) · Nature Immunology · doi:10.1038/ni.2081 · Cited by 232
Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
Liu, C., Qian, W., Qian, Y., Giltiay, N. V., Lu, Y., Swaidani, S., Misra, S., Deng, L., Chen, Z. J., & Li, X. (2009) · Science Signaling · doi:10.1126/scisignal.2000382 · Cited by 224
IL-25 in Atopic Dermatitis: A Possible Link between Inflammation and Skin Barrier Dysfunction?
Hvid, M., Vestergaard, C., Kemp, K., Christensen, G. B., Deleuran, B., & Deleuran, M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.277 · Cited by 219
The activation and regulation of IL-17 receptor mediated signaling
Song, X., & Qian, Y. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.014 · Cited by 206
Reich, K., Papp, K. A., Matheson, R. T., Tu, J. H., Bissonnette, R., Bourcier, M., Gratton, D., Kunynetz, R. A., Poulin, Y., Rosoph, L. A., et al. (2015) · Experimental Dermatology · doi:10.1111/exd.12710 · Cited by 204
Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
Hot, A., & Miossec, P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143768 · Cited by 201
Yamaguchi, Y., Fujio, K., Shoda, H., Okamoto, A., Tsuno, N. H., Takahashi, K., & Yamamoto, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.7128 · Cited by 195
Kim, M. R., Manoukian, R., Yeh, R., Silbiger, S. M., Danilenko, D. M., Scully, S., Sun, J., DeRose, M. L., Stolina, M., Chang, D., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0012 · Cited by 188
Pan, G., French, D., Mao, W., Maruoka, M., Risser, P., Lee, J., Foster, J., Aggarwal, S., Nicholes, K., Guillet, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6559 · Cited by 184
Zrioual, S., Ecochard, R., Tournadre, A., Lenief, V., Cazalis, M.-A., & Miossec, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801967 · Cited by 169
A Protective Role by Interleukin-17F in Colon Tumorigenesis
Tong, Z., Yang, X. O., Yan, H., Liu, W., Niu, X., Shi, Y., Fang, W., Xiong, B., Wan, Y., & Dong, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034959 · Cited by 155
Hwang, S., & Kim, H. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13153-0 · Cited by 154
Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis
Daudén, E., Castañeda, S., Suárez, C., García‐Campayo, J., Blasco, A. J., Aguilar, M. D., Ferrándiz, C., Puig, L., Sánchez‐Carazo, J. L., & on behalf of the Working Group on Comorbidity in Psoriasis (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12024 · Cited by 144
Glatt, S., Helmer, E., Haier, B., Strimenopoulou, F., Price, G., Vajjah, P., Harari, O., Lambert, J., & Shaw, S. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13185 · Cited by 142
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut
Caruso, R., Sarra, M., Stolfi, C., Rizzo, A., Fina, D., Fantini, M. C., Pallone, F., MacDonald, T. T., & Monteleone, G. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.049 · Cited by 141
Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation
Reynolds, J. M., Lee, Y.-H., Shi, Y., Wang, X., Angkasekwinai, P., Nallaparaju, K. C., Flaherty, S., Chang, S. H., Watarai, H., & Dong, C. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.008 · Cited by 135
IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth
Jungnickel, C., Schmidt, L. H., Bittigkoffer, L., Wolf, L., Wolf, A., Ritzmann, F., Kamyschnikow, A., Herr, C., Menger, M. D., Spieker, T., et al. (2017) · Oncogene · doi:10.1038/onc.2017.28 · Cited by 129
Keijsers, R. R. M. C., Hendriks, A. G. M., van Erp, P. E. J., van Cranenbroek, B., van de Kerkhof, P. C. M., Koenen, H. J. P. M., & Joosten, I. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.526 · Cited by 121
IL ‐25 in allergic inflammation
Xu, M., & Dong, C. (2017) · Immunological Reviews · doi:10.1111/imr.12558 · Cited by 120
Cutting Edge: Regulation of Intestinal Inflammation and Barrier Function by IL-17C
Reynolds, J. M., Martínez, G., Nallaparaju, K. C., Chang, S. H., Wang, Y.-H., & Dong, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103014 · Cited by 119
Vandeghinste, N., Klattig, J., Jagerschmidt, C., Lavazais, S., Marsais, F., Haas, J. D., Auberval, M., Lauffer, F., Moran, T., Ongenaert, M., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.01.036 · Cited by 117
The many faces of interleukin-17 in inflammatory skin diseases
Speeckaert, R., Lambert, J., Grine, L., Gele, M. V., Schepper, S. D., & van Geel, N. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14703 · Cited by 103
IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts
Letuve, S., Lajoie-Kadoch, S., Audusseau, S., Rothenberg, M. E., Fiset, P., Ludwig, M. S., & Hamid, Q. A. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.025 · Cited by 102
HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization
Herjan, T., Yao, P., Qian, W., Li, X., Liu, C., Bulek, K., Sun, D., Yang, W.-P., Zhu, J., He, A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203315 · Cited by 95
TH17 Cell Induction and Effects of IL-17A and IL-17F Blockade in Experimental Colitis
Schmidt, E. G. W., Larsen, H. L., Kristensen, N. N., Poulsen, S. S., Pedersen, A. M. L., Claësson, M. H., & Pedersen, A. E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318286fa1c · Cited by 95
Keratinocyte-Derived IL-17E Contributes to Inflammation in Psoriasis
Senra, L., Stalder, R., Martínez, D. Á., Chizzolini, C., Boehncke, W., & Brembilla, N. C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.009 · Cited by 95
Self-citationInvolvement of IL-17F via the induction of IL-6 in psoriasis
藤島, 沙., Watanabe, H., Kawaguchi, M., Suzuki, T., Matsukura, S., Homma, T., Howell, B. G., Hizawa, N., Mitsuya, T., Huang, S.-K., et al. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1033-8 · Cited by 90
Friedrich, M., Diegelmann, J., Schauber, J., Auernhammer, C. J., & Brand, S. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.124 · Cited by 87
Functional Characterization of IL-17F as a Selective Neutrophil Attractant in Psoriasis
Watanabe, H., Kawaguchi, M., 藤島, 沙., Ogura, M., Matsukura, S., Takeuchi, H. T., Ohba, M., Sueki, H., Kokubu, F., Hizawa, N., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.294 · Cited by 87
IL-17B: A new area of study in the IL-17 family
Bie, Q., Jin, C., Zhang, B., & Dong, H. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.07.004 · Cited by 87
Mutual upregulation of endothelin‐1 and IL ‐25 in atopic dermatitis
Aktar, M. K., Kido‐Nakahara, M., Furue, M., & Nakahara, T. (2015) · Allergy · doi:10.1111/all.12633 · Cited by 84
Angkasekwinai, P., Srimanote, P., Wang, Y., Pootong, A., Sakolvaree, Y., Pattanapanyasat, K., Chaicumpa, W., Chaiyaroj, S. C., & Dong, C. (2013) · Infection and Immunity · doi:10.1128/iai.00646-13 · Cited by 83
Yoshiga (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000032 · Cited by 83
MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation
Monin, L., Gudjonsson, J. E., Childs, E. E., Amatya, N., Xing, X., Verma, A. H., Coleman, B. M., Garg, A. V., Killeen, M., Mathers, A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601551 · Cited by 82
Roth, S. A., Simanski, M., Rademacher, F., Schröder, L. C., & Harder, J. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.313 · Cited by 81
Kim, B. E., Bin, L., Ye, Y., Ramamoorthy, P., & Leung, D. Y. M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.223 · Cited by 78
One SNP at a Time: Moving beyond GWAS in Psoriasis
Ray-Jones, H. F., Eyre, S., Barton, A. C., & Warren, R. B. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.11.025 · Cited by 77
Johansen, C., Vinter, H., Soegaard-Madsen, L., Olsen, L. R., Steiniche, T., Iversen, L., & Kragballe, K. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10036.x · Cited by 76
Chamian, F., & Krueger, J. G. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000129715.35024.50 · Cited by 76
Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis
Whibley, N., Tritto, E., Traggiai, E., Kolbinger, F., Moulin, P., Brees, D., Coleman, B. M., Mamo, A. J., Garg, A. V., Jaycox, J. R., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0915-428r · Cited by 72
Neutrophils produce interleukin-17B in rheumatoid synovial tissue
Kouri, V., Olkkonen, J., Ainola, M., Li, T.-F., Björkman, L. I., Konttinen, Y. T., & Mandelin, J. (2013) · Rheumatology · doi:10.1093/rheumatology/ket309 · Cited by 70
Friedrich, M., Tillack, C., Wollenberg, A., Schauber, J., & Brand, S. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000198 · Cited by 70
Gut-Busters: IL-17 Ain’t Afraid of No IL-23
Whibley, N., & Gaffen, S. L. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.001 · Cited by 68
Johansen, C., Riis, J. L., Gedebjerg, A., Kragballe, K., & Iversen, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240671 · Cited by 67
Batalla, A., Coto, E., González‐Lara, L., González-Fernández, D., Gómez, J., Fernández-Aranguren, T., Queiró, R., Santos‐Juanes, J., López‐Larrea, C., & Coto‐Segura, P. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.06.011 · Cited by 64
Sarkar, S., Justa, S., Brucks, M., Endres, J., Fox, D. A., Zhou, X., Alnaimat, F., Whitaker, B., Wheeler, J. C., Jones, B. H., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12376 · Cited by 63
Moore, E. E., Presnell, S., Garrigues, U., Guilbot, A., Leguern, É., Smith, D. L., Yao, L. Y., Whitmore, T. E., Gilbert, T., Palmer, T. D., et al. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00250-4 · Cited by 58
IL-25 Induces Both Inflammation and Skin Barrier Dysfunction in Atopic Dermatitis
Deleuran, M. S., Hvid, M., Kemp, K., Christensen, G. B., Deleuran, B. W., & Vestergaard, C. (2012) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000331871 · Cited by 56
IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice
Mantani, P. T., Dunér, P., Bengtsson, E., Alm, R., Ljungcrantz, I., Söderberg, I., Sundius, L., To, F., Nilsson, J. Å., Björkbacka, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117255 · Cited by 53
Fritz, Y., Klenotic, P. A., Swindell, W. R., Yin, Z. Q., Groft, S. G., Zhang, L., Baliwag, J., Camhi, M. I., Diaconu, D., Young, A. B., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.10.021 · Cited by 53
Prieto‐Pérez, R., Solano-López, G., Cabaleiro, T., Román, M. C., Ochoa, D., Talegón, M., Baniandrés, O., López-Estebaranz, J. L., de la Cueva, P., Daudén, E., et al. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.107 · Cited by 52
Liu, D., Cao, T., Wang, N., Liu, C., Ma, N., Tu, R., & Min, X. (2016) · Scientific Reports · doi:10.1038/srep36002 · Cited by 52
Suto, H., Nambu, A., Morita, H., Yamaguchi, S., Numata, T., Yoshizaki, T., Shimura, E., Arae, K., Asada, Y., Motomura, K., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.12.1007 · Cited by 51
Lonati, P. A., Brembilla, N. C., Montanari, E., Fontao, L., Gabrielli, A., Vettori, S., Valentini, G., Laffitte, E., Kaya, G., Meroni, P. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105008 · Cited by 49
Self-citationGümüş, P., Buduneli, E., Bıyıkoğlu, B., Aksu, K., Saraç, F., Nile, C. J., Lappin, D. F., & Buduneli, N. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.120595 · Cited by 49
Immunolocalization of IL-17A, IL-17B, and Their Receptors in Chondrocytes During Fracture Healing
Kokubu, T., Haudenschild, D. R., Moseley, T. A., Rose, L., & Reddi, A. H. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.7a7223.2007 · Cited by 48
Butcher, M. J., Waseem, T. C., & Galkina, E. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307892 · Cited by 46
The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney
Ramani, K., Garg, A. V., Jawale, C. V., Conti, H. R., Whibley, N., Jackson, E. K., Shiva, S. S., Horne, W., Kolls, J. K., Gaffen, S. L., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005952 · Cited by 43
Toll-Like Receptor 5 Engagement Induces Interleukin-17C Expression in Intestinal Epithelial Cells
Im, E., Jung, J., & Rhee, S. H. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0053 · Cited by 41
Iboshi, Y., Nakamura, K., Fukaura, K., Iwasa, T., Ogino, H., Sumida, Y., Ihara, E., Akiho, H., Harada, N., & Nakamuta, M. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1221-1 · Cited by 36
Stamp, L. K., Easson, A., Lehnigk, U., Highton, J., & Hessian, P. A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23455 · Cited by 35
Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine models
Golden, J. B., Wang, Y., Fritz, Y., Diaconu, D., Zhang, X., Debanne, S. M., Simon, D. I., McCormick, T. S., & Ward, N. L. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0738-z · Cited by 29
The ancient cytokine IL-17D is regulated by Nrf2 and mediates tumor and virus surveillance
Seelige, R., Washington, A., & Bui, J. D. (2017) · Cytokine · doi:10.1016/j.cyto.2016.11.017 · Cited by 21
Babaloo, Z., Babaie, F., Farhoodi, M., Aliparasti, M. R., Baradaran, B., Almasi, S., & Hoseini, A. (2010) · PubMed · doi:10.22034/iji.2010.17059 · Cited by 19
Mantani, P. T., Dunér, P., Bengtsson, E., Ljungcrantz, I., Sundius, L., To, F., Nilsson, J. Å., Björkbacka, H., & Fredrikson, G. N. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000292 · Cited by 16
Relationship Between Serum Interleukin-17F Level and Severity of Atopic Dermatitis in Children
Park, Y. A., Kim, Y. H., Sol, I. S., Yoon, S. H., Hong, J. Y., Kim, M. N., Lee, K. E., Kim, K. W., Kim, K.-E., & Sohn, M. H. (2015) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2014.0482 · Cited by 12
Otsuka, A., Miyachi, Y., & Kabashima, K. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04345.x · Cited by 6
Iboshi, Y., Nakamura, K., Fukaura, K., Iwasa, T., Ogino, H., Sumida, Y., Ihara, E., Akiho, H., Harada, N., & Nakamuta, M. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1231-z · Cited by 5
Cited by
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Ghoreschi, K., Balato, A., Enerbäck, C., & Sabat, R. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00184-7 · Cited by 668
Signaling pathways and targeted therapies for psoriasis
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 427
Furue, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155382 · Cited by 419
Moving towards personalized treatments of immune-related adverse events
Esfahani, K., Elkrief, A., Calabrese, C., Lapointe, R., Hudson, M., Routy, B., Miller, W. H., & Calabrese, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0352-8 · Cited by 351
Interleukin-17A and Keratinocytes in Psoriasis
Furue, M., Furue, K., Tsuji, G., & Nakahara, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041275 · Cited by 300
Metadata
- Authors
- Brembilla, N. C., Senra, L., & Boehncke, W.-H.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-08-02
- Volume
- 9
- Pages
- 1682-1682
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2883191655
- Cited by
- 475
- References
- 134
- FWCI
- 15.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.